Free Trial

InterCure (NASDAQ:INCR) Trading Down 3.5% - Should You Sell?

InterCure logo with Medical background

Shares of InterCure Ltd. (NASDAQ:INCR - Get Free Report) dropped 3.5% during mid-day trading on Tuesday . The company traded as low as $1.49 and last traded at $1.50. Approximately 34,007 shares changed hands during trading, an increase of 31% from the average daily volume of 25,980 shares. The stock had previously closed at $1.55.

InterCure Trading Up 0.7%

The stock's 50-day moving average price is $1.53 and its 200-day moving average price is $1.54. The company has a current ratio of 1.73, a quick ratio of 1.18 and a debt-to-equity ratio of 0.34.

Hedge Funds Weigh In On InterCure

A hedge fund recently bought a new stake in InterCure stock. Moore Capital Management LP acquired a new stake in InterCure Ltd. (NASDAQ:INCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 97,273 shares of the company's stock, valued at approximately $156,000. Moore Capital Management LP owned about 0.21% of InterCure as of its most recent filing with the SEC. Hedge funds and other institutional investors own 8.34% of the company's stock.

About InterCure

(Get Free Report)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

Featured Articles

Should You Invest $1,000 in InterCure Right Now?

Before you consider InterCure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.

While InterCure currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines